Ping An Biomedical Co., Ltd. (PASW)

HK — Industrials Sector
Peers: LBGJ  PSIG  ZDAI  OFAL  TLIH  ARTW  GRNQ  INLF  VRME  LSH 

Automate Your Wheel Strategy on PASW

With Tiblio's Option Bot, you can configure your own wheel strategy including PASW - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

News

All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital
PASW
Published: March 19, 2026 by: GlobeNewsWire
Sentiment: Neutral

HONG KONG, March 19, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that shareholders have approved all five resolutions at the company's 2026 Annual General Meeting, providing full authorization for an overhaul of its share capital structure, the introduction of high‑vote Class B shares, a targeted share exchange with a major shareholder, and a large‑scale share consolidation. Authorised Share Capital Changes Shareholders resolved by an ordinary resolution that, the Company authorised share capital of the Company be amended in the manner and sequence set out below with immediate effect …

Read More
image for news All Resolutions Passed at Ping An Biomedical AGM, Clearing Path for Restructured Share Capital
Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry
PASW
Published: January 09, 2026 by: GlobeNewsWire
Sentiment: Neutral

HONG KONG, Jan. 09, 2026 (GLOBE NEWSWIRE) -- Ping An Biomedical Co., Ltd (NASDAQ: PASW) (hereinafter referred to as “Ping An Bio”) announced that it has entered into a non-binding memorandum (the “Investment Memorandum”) with Future Biotechnology Group Co., Ltd (hereinafter referred to as “Future Biotechnology Group”). The Investment Memorandum outlines an initial investment of US$30 million to be paid in cash, as well as subsequent acquisitions with a consideration, in aggregate, of US$60 million to be settled in cash and share issuances (the “Consideration Shares”).

Read More
image for news Ping An Biomedical Co., Ltd Announces Strategic Investment in Future Biotechnology Group to Advance Collaborative Development of the Biopharmaceutical Industry

About Ping An Biomedical Co., Ltd. (PASW)

  • IPO Date 2025-07-18
  • Website http://www.majestic-holdings-temp.flywheelsites.com
  • Industry Industrial - Distribution
  • CEO Pijun Liu
  • Employees 7

Ping An Biomedical Co., Ltd. engages in the provision of supply chain management services in the apparel industry delivering one-stop solutions to customers for a broad range of yarn products, textiles, and finished garments. It operates through the Yarns and Finished Garments segments. The company was founded by Yuk Yin Li and Sek Yan Ko in 2013 and is headquartered in Hong Kong.